| Code | CSB-MP008734HU-WD |
| Abbreviation | Recombinant Human FLT-3L protein, partial (Active) |
| MSDS | |
| Size | Inquiry |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
FLT3 ligand drives the expansion and differentiation of hematopoietic progenitors and dendritic cells, making it a critical tool for studies of myeloid development and immune cell mobilization. This recombinant protein, spanning residues 27–184 of the mature human sequence, demonstrates potent bioactivity with an ED50 ≤ 1.0 ng/ml in OCI-AML5 proliferation assays, corresponding to a specific activity ≥ 1 × 10⁶ units/mg that supports dose-response experiments in primary hematopoietic cultures and dendritic cell differentiation protocols. Endotoxin levels ≤ 10 EU/mg satisfy the stringent criteria expected for immune cell functional assays, where LPS contamination would confound readouts of cytokine-driven activation or JAK/STAT signaling. Produced in mammalian cells to preserve native glycosylation and folding, the protein meets the quality thresholds commonly required for in vivo hematopoiesis models, antibody validation workflows, and reference standards in FLT3L detection assays, with purity exceeding 95% by SDS-PAGE.
There are currently no reviews for this product.